Shanghai Jiaotong University School of Medicine Ruijin Hospital

Shanghai, Shanghai Municipality 200025

1 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Colitis, Ulcerative, Crohn's Disease, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL, Ulcerative Colitis

Studies at this site

• A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) — Recruiting now
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early